Solventum Corporation (SOLV) Market Cap & Valuation Ratios
Solventum Corporation (SOLV) has a market cap of $14.5B and a price-to-sales ratio of 1.8, with earnings according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
SOLVSolventum CorporationFollow SOLV — free
—
Price chart with a free account
- Market cap
- 14.5B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 5 Nov, in 12 days
Peers
medical instruments & supplies · nearest by market cap · trailing 12 months| Company | Mkt cap, $B | P/E | EV/Sales | EV/EBITDA | FCF yield | Rev. growth | Op. margin | ROIC |
|---|---|---|---|---|---|---|---|---|
| SOLV | 15 | — | 2.3 | 7.4 | -0.8% | -0.9% | 25% | 17% |
| RMD | 36 | 24.2 | 6.3 | 17.1 | 4.5% | +10% | 33% | 27% |
| WST | 28 | 50.2 | 8.2 | 31.8 | 1.6% | +12% | 20% | 20% |
| BAX | 13 | — | 1.8 | 30.0 | 6.2% | +5% | -2% | -2% |
| AVTR | 12 | — | 2.3 | 128.6 | 3.9% | -2% | -5% | -3% |
| COO | 12 | — | 3.3 | 15.1 | 5.8% | +5% | 13% | 3% |
| ALGN | 11 | 26.9 | 2.4 | 12.3 | 5.8% | +4% | 13% | 13% |
| RGEN | 10.0 | 242.4 | 12.4 | 67.8 | 1.1% | +16% | 8% | 3% |
| ATR | 8.0 | 22.8 | 2.3 | 11.7 | 3.9% | +9% | 12% | 10% |
| BLCO | 6.2 | — | 2.1 | 15.0 | 2.2% | +9% | 6% | 2% |
| TFX | 5.8 | — | 3.7 | 43.0 | 2.9% | +31% | 2% | 0.6% |
| Median of these 10 | 26.9 | 2.8 | 23.6 | 3.9% | +9% | 10% | 3% |
; EV/Sales 2.3 vs. 2.8.
Growth vs. price
each dot a company · hover or tap for valuesSOLV and BAX and AVTR and COO and BLCO and TFX have no P/E (earnings not positive) and are left out · hover or tap a dot for values.
Solventum Corporation — questions
- What is Solventum Corporation's market cap?
- $14.5B.
- What is Solventum Corporation's price-to-sales ratio?
- 1.8.
Every figure on this page comes from Solventum Corporation's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.